These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37312019)

  • 1. Effect of regional versus general anesthesia on recurrence of non-muscle invasive bladder cancer: a systematic review and meta-analysis of eight retrospective cohort studies.
    Wang Y; Song Y; Qin C; Zhang C; Du Y; Xu T
    BMC Anesthesiol; 2023 Jun; 23(1):201. PubMed ID: 37312019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.
    Baba Y; Kikuchi E; Shigeta K; Ogihara K; Matsushima M; Nishimoto Y; Murata Y; Asakura H; Oyama M; Mizuno R; Oya M
    Int J Clin Oncol; 2021 Nov; 26(11):2094-2103. PubMed ID: 34357470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of regional anesthesia with oncological outcomes in patients receiving surgery for bladder cancer: A meta-analysis of observational studies.
    Illias AM; Yu KJ; Wu SC; Cata JP; Tsai YF; Hung KC
    Front Oncol; 2023; 13():1097637. PubMed ID: 36910609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Anesthesia is Associated with Lower Recurrence Rates after Resection of Nonmuscle Invasive Bladder Cancer.
    Koumpan Y; Jaeger M; Mizubuti GB; Tanzola R; Jain K; Hosier G; Hopman W; Siemens DR
    J Urol; 2018 Apr; 199(4):940-946. PubMed ID: 29154849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.
    Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013776. PubMed ID: 34850382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hexaminolevulinate (HAL) -guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized controlled trials.
    Zhao H; Peng P; Luo Z; Liu H; Sun J; Wang X; Jia Q; Yang Z
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103220. PubMed ID: 36462704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance versus non-maintenance intravesical Bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: A systematic review and meta-analysis of randomized clinical trials.
    Chen S; Zhang N; Shao J; Wang X
    Int J Surg; 2018 Apr; 52():248-257. PubMed ID: 29499363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
    Yang H; Lin J; Gao P; He Z; Kuang X; Li X; Fu H; Du D
    Urol Int; 2020; 104(5-6):402-409. PubMed ID: 31910427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
    Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
    Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis.
    Ślusarczyk A; Zapała P; Zapała Ł; Radziszewski P
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2673-2691. PubMed ID: 36404390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Transurethral Laser Surgery Versus Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis and Systematic Review.
    Xu J; Wang C; Ouyang J; Sun J; Hu C
    Urol Int; 2020; 104(9-10):810-823. PubMed ID: 32460292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.
    Shelley MD; Jones G; Cleves A; Wilt TJ; Mason MD; Kynaston HG
    BJU Int; 2012 Feb; 109(4):496-505. PubMed ID: 22313502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical gemcitabine for non-muscle invasive bladder cancer.
    Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Uhlig A; Strauss A; Seif Amir Hosseini A; Lotz J; Trojan L; Schmid M; Uhlig J
    Eur Urol Focus; 2018 Dec; 4(6):924-936. PubMed ID: 28888813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of regional anaesthesia only versus general anaesthesia on cancer recurrence rate: A systematic review and meta-analysis with trial sequential analysis.
    Ang E; Ng KT; Lee ZX; Ti LK; Chaw SH; Wang CY
    J Clin Anesth; 2020 Dec; 67():110023. PubMed ID: 32805685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of regional and general anesthesia effects on 5 year survival and cancer recurrence after transurethral resection of the bladder tumor: a retrospective analysis.
    Jang D; Lim CS; Shin YS; Ko YK; Park SI; Song SH; Kim BJ
    BMC Anesthesiol; 2016 Mar; 16():16. PubMed ID: 26971194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.